The Julius Maximilian University of Würzburg is a public research university in Würzburg, Germany. The University of Würzburg is one of the oldest institutions of higher learning in Germany, having been founded in 1402. The university initially had a brief run and was closed in 1415.

During the past decade, University of Würzburg conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Würzburg" #1 sponsor was "University of Wuerzburg" with 4 trials, followed by "Wuerzburg University Hospital" with 2 trials sponsored, "Alexion" with 1 trials sponsored, "Birmingham Community Healthcare NHS" with 1 trials sponsored and "Cochlear" with 1 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Würzburg" #1 collaborator was "Deutsche Krebshilfe e.V., Bonn (Germany)" with 2 trials as a collaborator, "University of Wuerzburg" with 2 trials as a collaborator, "Academic Centre for Dentistry in Amsterdam" with 1 trials as a collaborator, "Alcon Research" with 1 trials as a collaborator and "Charite University, Berlin, Germany" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "University of Würzburg" are "Adrenocortical Carcinoma" (2 trials), "Aspiration Pneumonitis" (2 trials), "Atelectasis" (2 trials), "Bronchospasm" (2 trials) and "Leukemia" (2 trials). Many other conditions were trialed in "University of Würzburg" in a lesser frequency.

Most popular intervention types in "University of Würzburg" are "Drug" (9 trials), "Biological" (3 trials), "Device" (3 trials), "Other" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "cytarabine" (3 trials), "Perioperative pulmonary function tests" (2 trials), "cyclophosphamide" (2 trials), "filgrastim" (2 trials) and "peripheral blood stem cell transplantation" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Würzburg" are 21 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of Würzburg". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in University of Würzburg, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Würzburg, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".

University of Würzburg has several departments that took part in Clinical trials: "Dept. of Medicine I, University of Wuerzburg" - 4 trials, "Universitätsklinikum Würzburg, Comprehensive Cancer Center Mainfranken" - 3 trials, "Uniklinikum, Comprehensive Cancer Center Mainfranken; Interdisziplinäres Studienzentrum mit ECTU" - 2 trials